BMRN

BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061G101

Market Cap
-
Sector
Healthcare
Institutional Owners
0
Institutional Value
-

About

BioMarin Pharmaceutical Inc. is a global biotechnology company focused on developing and commercializing innovative therapies for rare genetic diseases. With a strong emphasis on enzyme replacement therapies and other advanced biologics, the company addresses unmet medical needs in areas such as hemophilia, metabolic disorders, and pediatric conditions. BioMarin has established itself as a leader in the orphan drug space by leveraging its expertise in genetic research to deliver targeted treatments for small patient populations.

Institutional Holders

Loading...